Faye Feller - Jun 6, 2024 Form 4 Insider Report for GERON CORP (GERN)

Role
EVP, Chief Medical Officer
Signature
/s/ Scott A. Samuels for Faye Feller
Stock symbol
GERN
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 04:10 PM
Previous filing
Feb 16, 2024
Next filing
Jun 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GERN Employee Stock Option (right to buy) Award $0 +50K $0.00 50K Jun 6, 2024 Common Stock 50K $1.06 Direct F1
transaction GERN Employee Stock Option (right to buy) Award $0 +200K $0.00 200K Jun 6, 2024 Common Stock 200K $1.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance-based stock option granted on February 16, 2022 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.
F2 Performance-based stock option granted on July 9, 2022 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.